Sugar-Coating Nothing

Last week, I found myself sitting across from a former Abbott (ABT) executive at a quiet corner table in Chicago’s Union League Club, listening to something that made my biochemistry background tingle with excitement. We were discussing the recent market pummeling of Abbott shares following their third-quarter earnings, and he leaned forward with that conspiratorial […]